These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31724161)
1. Annexin-A1 deficiency exacerbates pathological remodelling of the mesenteric vasculature in insulin-resistant, but not insulin-deficient, mice. Jelinic M; Kahlberg N; Leo CH; Ng HH; Rosli S; Deo M; Li M; Finlayson S; Walsh J; Parry LJ; Ritchie RH; Qin CX Br J Pharmacol; 2020 Apr; 177(7):1677-1691. PubMed ID: 31724161 [TBL] [Abstract][Full Text] [Related]
2. Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes. Purvis GSD; Collino M; Loiola RA; Baragetti A; Chiazza F; Brovelli M; Sheikh MH; Collotta D; Cento A; Mastrocola R; Aragno M; Cutrin JC; Reutelingsperger C; Grigore L; Catapano AL; Yaqoob MM; Norata GD; Solito E; Thiemermann C Front Immunol; 2019; 10():571. PubMed ID: 30972066 [TBL] [Abstract][Full Text] [Related]
3. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Gastardelo TS; Damazo AS; Dalli J; Flower RJ; Perretti M; Oliani SM Am J Pathol; 2009 Jan; 174(1):177-83. PubMed ID: 19095957 [TBL] [Abstract][Full Text] [Related]
4. Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy. Wu L; Liu C; Chang DY; Zhan R; Sun J; Cui SH; Eddy S; Nair V; Tanner E; Brosius FC; Looker HC; Nelson RG; Kretzler M; Wang JC; Xu M; Ju W; Zhao MH; Chen M; Zheng L Kidney Int; 2021 Jul; 100(1):107-121. PubMed ID: 33675846 [TBL] [Abstract][Full Text] [Related]
5. Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes. Purvis GSD; Chiazza F; Chen J; Azevedo-Loiola R; Martin L; Kusters DHM; Reutelingsperger C; Fountoulakis N; Gnudi L; Yaqoob MM; Collino M; Thiemermann C; Solito E Diabetologia; 2018 Feb; 61(2):482-495. PubMed ID: 29085990 [TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of the palmitate-induced myotube secretome reveals involvement of the annexin A1-formyl peptide receptor 2 (FPR2) pathway in insulin resistance. Yoon JH; Kim D; Jang JH; Ghim J; Park S; Song P; Kwon Y; Kim J; Hwang D; Bae YS; Suh PG; Berggren PO; Ryu SH Mol Cell Proteomics; 2015 Apr; 14(4):882-92. PubMed ID: 25616869 [TBL] [Abstract][Full Text] [Related]
7. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496 [TBL] [Abstract][Full Text] [Related]
8. Involvement of the annexin A1-Fpr anti-inflammatory system in the ocular allergy. Marmorato MP; Gimenes AD; Andrade FEC; Oliani SM; Gil CD Eur J Pharmacol; 2019 Jan; 842():298-305. PubMed ID: 30419240 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro. Girol AP; Mimura KK; Drewes CC; Bolonheis SM; Solito E; Farsky SH; Gil CD; Oliani SM J Immunol; 2013 Jun; 190(11):5689-701. PubMed ID: 23645879 [TBL] [Abstract][Full Text] [Related]
10. Annexin A1 mediates the anti-inflammatory effects during the granulocytic differentiation process in all-trans retinoic acid-treated acute promyelocytic leukemic cells. Tsai WH; Chien HY; Shih CH; Lai SL; Li IT; Hsu SC; Kou YR; Hsu HC J Cell Physiol; 2012 Nov; 227(11):3661-9. PubMed ID: 22378018 [TBL] [Abstract][Full Text] [Related]
11. Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature. Pederzoli-Ribeil M; Maione F; Cooper D; Al-Kashi A; Dalli J; Perretti M; D'Acquisto F Blood; 2010 Nov; 116(20):4288-96. PubMed ID: 20705760 [TBL] [Abstract][Full Text] [Related]
12. Loss of Endothelial Annexin A1 Aggravates Inflammation-Induched Vascular Aging. You Q; Ke Y; Chen X; Yan W; Li D; Chen L; Wang R; Yu J; Hong H Adv Sci (Weinh); 2024 Apr; 11(15):e2307040. PubMed ID: 38358087 [TBL] [Abstract][Full Text] [Related]
13. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma. Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767 [TBL] [Abstract][Full Text] [Related]
14. The Novel Small-molecule Annexin-A1 Mimetic, Compound 17b, Elicits Vasoprotective Actions in Streptozotocin-induced Diabetic Mice. Marshall SA; Qin CX; Jelinic M; O'Sullivan K; Deo M; Walsh J; Li M; Parry LJ; Ritchie RH; Leo CH Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085666 [TBL] [Abstract][Full Text] [Related]
15. Annexin-A1: Therapeutic Potential in Microvascular Disease. Purvis GSD; Solito E; Thiemermann C Front Immunol; 2019; 10():938. PubMed ID: 31114582 [TBL] [Abstract][Full Text] [Related]
16. Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation. Senchenkova EY; Ansari J; Becker F; Vital SA; Al-Yafeai Z; Sparkenbaugh EM; Pawlinski R; Stokes KY; Carroll JL; Dragoi AM; Qin CX; Ritchie RH; Sun H; Cuellar-Saenz HH; Rubinstein MR; Han YW; Orr AW; Perretti M; Granger DN; Gavins FNE Circulation; 2019 Jul; 140(4):319-335. PubMed ID: 31154815 [TBL] [Abstract][Full Text] [Related]